Published in Transplantation on December 01, 1984
Complement in organ transplantation. Contributions to inflammation, injury, and rejection. Transplantation (1995) 2.36
Renal disease in type I glycogen storage disease. N Engl J Med (1988) 1.45
Nosocomial H1N1 infection during 2010-2011 pandemic: a retrospective cohort study from a tertiary referral hospital. J Hosp Infect (2012) 1.41
False-positive antineutrophil cytoplasmic antibody in aspergillosis with oxalosis. Arch Pathol Lab Med (1995) 1.39
Eosinophilic intracytoplasmic globules in pulmonary adenocarcinomas: a histochemical, immunohistochemical, and ultrastructural study of six cases. Hum Pathol (1989) 1.39
The distribution of organs for transplantation. What is fair and practical? N C Med J (1991) 1.37
Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection. Transplantation (1987) 1.31
Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation (2001) 1.24
Improved renal function in mouse kidney allografts lacking MHC class I antigens. J Immunol (1993) 1.24
Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol (1996) 1.18
Familial encephalopathy with neuroserpin inclusion bodies. Am J Pathol (1999) 1.16
Measuring contributions to the research mission of medical schools. Acad Med (2000) 1.12
Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation. N Engl J Med (1986) 1.11
Benefits of HLA-A and HLA-B matching on graft and patient outcome after cadaveric-donor renal transplantation. N Engl J Med (1984) 1.10
Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology (1988) 1.10
Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). Mol Immunol (1999) 1.08
Humoral rejection of rat hepatic transplants by passive transfer of serum. Transplant Proc (1987) 1.07
Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med (1994) 1.05
Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia. Ann Neurol (1988) 1.02
Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. J Immunol (1994) 0.98
Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice. J Infect Dis (1994) 0.98
C6 produced by macrophages contributes to cardiac allograft rejection. Am J Pathol (1999) 0.98
HMB-45-positive malignant lymphoma. A case report with literature review of aberrant HMB-45 reactivity. Arch Pathol Lab Med (1991) 0.97
Pathology of human mesothelioma. Etiologic and diagnostic considerations. Pathol Annu (1987) 0.97
The expression of major histocompatibility complex and leukocyte antigens by cells in the rat cornea. Transplantation (1986) 0.97
HLA matching in renal transplantation. N Engl J Med (1994) 0.96
Cellular events in tolerance. IV. The effect of a graft-versus-host reaction and endotoxin on hapten- and carrier-specific tolerance. Eur J Immunol (1974) 0.96
The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol (1984) 0.95
Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation (1999) 0.93
Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation (1982) 0.93
Immunohistochemical manifestations of unilateral kidney ischemia. Clin Transplant (1996) 0.92
Therapeutic hypothermia: heat transfer from warmed tracheal tubes to oesophageal temperature probes poses risk of life-threatening overcooling. Br J Anaesth (2012) 0.92
Identification of donor factors predisposing to high discard rates of cadaver kidneys and increased graft loss within one year posttransplantation--SEOPF 1977-1982. South-Eastern Organ Procurement Foundation. Transplantation (1987) 0.91
Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses. Transplantation (1990) 0.91
Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol (1993) 0.91
Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies. Am J Cardiol (1983) 0.91
The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation (1984) 0.90
Multivariate analysis of risk factors in cadaver donor kidney transplantation. Transplantation (1986) 0.89
Causes of death in renal transplant recipients. A review of autopsy findings from 1966 through 1985. Arch Pathol Lab Med (1987) 0.89
Differential infiltration by CD45RO and CD45RA subsets of T cells associated with human heart allograft rejection. Am J Pathol (1993) 0.89
The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group. Transplantation (1995) 0.88
Benign human enterovirus becomes virulent in selenium-deficient mice. J Med Virol (1994) 0.88
Thromboxane receptor blockade reduces renal injury in murine lupus nephritis. Kidney Int (1992) 0.88
Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. Am J Clin Pathol (1985) 0.88
Coxsackievirus-induced chronic myocarditis in murine models. Eur Heart J (1995) 0.85
Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice. J Nutr (1994) 0.85
Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts. J Heart Lung Transplant (1998) 0.85
Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer. Clin Cancer Res (1997) 0.84
Beneficial effects of histocompatibility in high-risk corneal transplantation. Am J Ophthalmol (1982) 0.84
Expression of ABO blood group, hematopoietic, and other cell-specific antigens by cells in the human cornea. Cornea (1987) 0.84
Prognostic markers in resected stage I and II non small-cell lung cancer: an analysis of 260 patients with 5 year follow-up. Clin Lung Cancer (1999) 0.84
Hepatic and extrahepatic biosynthesis of complement factor C6 in the rat. J Immunol (1994) 0.84
Cellular events in tolerance. III. Carrier tolerance as a model for T cell unresponsiveness. J Immunol (1974) 0.84
The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Cancer Res (1994) 0.84
Predominant infiltration of rejecting human renal allografts with T cells expressing CD8 and CD45RO. Transplantation (1995) 0.84
The effects of carrier-specific helper T-cell tolerance on antibody avidity in the anti-hapten response. Cell Immunol (1976) 0.83
Inducible nitric oxide synthase in the lung and exhaled nitric oxide after hyperoxia. Am J Physiol (1999) 0.83
Complement as a mediator of vascular inflammation and activation in allografts. J Heart Lung Transplant (2000) 0.83
Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation (1988) 0.82
Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation (1982) 0.82
Adenovirus infection of the renal allograft with sparing of pancreas graft function in the recipient of a combined kidney-pancreas transplant. Transplantation (1998) 0.82
Immunohistochemical studies of cell differentiation in a juxtaglomerular tumor. Arch Pathol Lab Med (1982) 0.82
Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest (1997) 0.81
Effect of carrier-specific tolerance on the generation of helper cell function. Eur J Immunol (1976) 0.81
The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat. Transplantation (1995) 0.81
Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. Transplantation (1997) 0.81
The relationship of transfusion and presensitization with graft and patient survival. Transplant Proc (1982) 0.80
Glomerular injury in end-stage liver disease--role of circulating IgG and IgM immune complexes. Pediatr Nephrol (1993) 0.80
IgA nephropathy. Correlation of clinical and histologic features. Lab Invest (1983) 0.80
Characterization of a novel human corneal endothelial antigen. Invest Ophthalmol Vis Sci (1991) 0.80
Differential expression of T-cell receptor-V region determinants on infiltrating T cells in rejecting and nonrejecting human kidney, liver, and heart allografts. Transplant Proc (1993) 0.80
Renal allograft cell infiltrates associated with irreversible rejection. Transplantation (1985) 0.80
The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells. Transplantation (1991) 0.80
Involvement of the RAF1 locus, at band 3p25, in the 3p deletion of small-cell lung cancer. Genes Chromosomes Cancer (1991) 0.80
The association of pretransplant native nephrectomy with decreased renal allograft rejection. Transplantation (1984) 0.79
The timing of pretransplant transfusions and renal allograft survival. Transplantation (1984) 0.79
IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion. Transplantation (1992) 0.79
Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries. Transplantation (2001) 0.79
erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients. Cancer Epidemiol Biomarkers Prev (1994) 0.79
Affinity studies of human anti-MAG antibodies in neuropathy. J Neuroimmunol (1994) 0.79
Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients. Transplantation (1990) 0.79
Rapid serologic diagnosis of serum sickness from antithymocyte globulin therapy using enzyme immunoassay. Transplantation (1984) 0.78
CTLA4Ig inhibits alloantibody responses to repeated blood transfusions. Blood (1996) 0.78
IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion. Transplantation (1991) 0.78
Immunobiology of primary intracranial tumors. Part 8: Serological responses to active immunization of patients with anaplastic gliomas. J Neurosurg (1983) 0.78
Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated hyperacute rejection of a guinea pig cardiac xenograft. Transplantation (1995) 0.78
Hyperacute rejection of liver transplants in rats. Curr Surg (1986) 0.78
Microtubule assembly inhibition by porphyrins and related compounds. Photochem Photobiol (1987) 0.78
Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients. Transplant Proc (1993) 0.78
Characteristics of auto anti-idiotypic antibodies reactive with antibodies expressing the pathogenic idiotype, IdLNF1, in the (NZB x SWR)F1 model for lupus nephritis and its parental strains. J Autoimmun (1998) 0.77
Alloantibodies restore cardiac allograft rejection to IgKO mice. Transplant Proc (2001) 0.77
Prognostic significance of Lewis y antigen in resected stage I and II non-small cell lung cancer. Chest (1998) 0.77
The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival. Transplantation (1984) 0.77
Maintenance of increased Bcl-2 expression in uterine leiomyomas after GnRH agonist therapy. J Reprod Med (1999) 0.77